Why It Matters
The funding validates Dalan’s novel platform and provides the resources needed to scale a first‑of‑its‑kind invertebrate vaccine, opening a new market segment in animal health and potentially reshaping disease control in agriculture.
Deal Summary
Dalan Animal Health, a bioscience firm that created the first vaccine for invertebrates, announced the closure of a $3 million SAFE seed round. The financing was led by Good Growth Capital and Meach Cove Capital, along with other global investors, to advance its innate immunity platform.
Comments
Want to join the conversation?
Loading comments...